148 related articles for article (PubMed ID: 36444506)
1. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
Venkataswamy C; Vinayagam N; Shanmugasundaram S; Rai R
J Cutan Pathol; 2023 Mar; 50(3):259-265. PubMed ID: 36444506
[TBL] [Abstract][Full Text] [Related]
2. The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures.
Adaszewska A; Kalińska-Bienias A; Jagielski P; Woźniak K; Kowalewski C
J Cutan Pathol; 2020 Feb; 47(2):121-127. PubMed ID: 31603994
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of BIOCHIP Mosaic-based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
Arunprasath P; Rai R; Venkataswamy C
Indian Dermatol Online J; 2021; 12(1):105-109. PubMed ID: 33768030
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
Arunprasath P; Rai R; Venkataswamy C
Indian Dermatol Online J; 2020; 11(6):915-919. PubMed ID: 33344339
[TBL] [Abstract][Full Text] [Related]
7. Role of BIOCHIP Indirect Immunofluorescence Test in Cutaneous Vesiculobullous Diseases.
Tirumalae R; Kalegowda IY
Am J Dermatopathol; 2020 May; 42(5):322-328. PubMed ID: 31211701
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
9. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
[TBL] [Abstract][Full Text] [Related]
10. A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature.
Yang A; Xuan R; Murrell DF
Australas J Dermatol; 2019 Aug; 60(3):e173-e177. PubMed ID: 30968398
[TBL] [Abstract][Full Text] [Related]
11. Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus.
Yang A; Xuan R; Melbourne W; Tran K; Murrell DF
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):153-160. PubMed ID: 31260565
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Yang B; Wang C; Chen S; Chen X; Zhou G; Tian H; Yu M; Zhang D; Shi Z; Zhang F
Indian J Dermatol Venereol Leprol; 2011; 77(6):677-82. PubMed ID: 22016274
[TBL] [Abstract][Full Text] [Related]
13. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
14. Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses.
Grootenboer-Mignot S; Descamps V; Picard-Dahan C; Nicaise-Roland P; Prost-Squarcioni C; Leroux-Villet C; Champagnat C; Delaval A; Aucouturier F; Crickx B; Chollet-Martin S
Br J Dermatol; 2010 Apr; 162(4):743-50. PubMed ID: 19886889
[TBL] [Abstract][Full Text] [Related]
15. Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients.
Yang A; Xuan RR; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro JM; Mahmoudi H; Patsatsi A; Drenovska K; Vassileva S; Murrell DF
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2327-2333. PubMed ID: 31325388
[TBL] [Abstract][Full Text] [Related]
16. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.
van Beek N; Rentzsch K; Probst C; Komorowski L; Kasperkiewicz M; Fechner K; Bloecker IM; Zillikens D; Stöcker W; Schmidt E
Orphanet J Rare Dis; 2012 Aug; 7():49. PubMed ID: 22876746
[TBL] [Abstract][Full Text] [Related]
17. Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.
Rai R; Anand JB; Shanmugasekar C; Arunprasath P; Chaitra V; Zillikens D; Schimdt E
Indian J Dermatol Venereol Leprol; 2021; 87(6):787-791. PubMed ID: 34160166
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of serration pattern analysis by direct immunofluorescence in subepidermal autoimmune blistering diseases.
Sood R; Chatterjee D; De D; Nahar Saikia U; Mahajan R; Handa S; Dass Radotra B
Indian J Dermatol Venereol Leprol; 2023 Aug; ():1-6. PubMed ID: 37609723
[TBL] [Abstract][Full Text] [Related]
20. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
